Karyopharm Therapeutics Inc <KPTI.O>: RBC cuts target price to $8 from $16
KPTI•Related News

Imperial Q2 EPS CAD 4.52
IMO•

PGE files general rate case with Oregon regulators seeking 4.8% increase
POR•

GLOBAL MARKETS-Stocks climb as strong tech results reignite AI trade, yen swings
SPY•

Alnylam Pharmaceuticals Inc <ALNY.O>: Raymond James Cuts Target Price to $420 From $468
ALNY•

Viper Energy Inc <VNOM.O>: Raymond James cuts target price to $57 from $61
VNOM•